Targeting monoamine oxidase A for T cell–based cancer immunotherapy-Reference-Cited by-同舟云学术

Targeting monoamine oxidase A for T cell–based cancer immunotherapy

Published:2021-05-28 Issue:59 Volume:6 Page:
ISSN:2470-9468
Container-title:Science Immunology
language:en
Short-container-title:Sci. Immunol.

Author:

Wang Xi¹^ORCID,Li Bo¹^ORCID,Kim Yu Jeong¹,Wang Yu-Chen¹,Li Zhe¹,Yu Jiaji¹,Zeng Samuel¹,Ma Xiaoya¹^ORCID,Choi In Young¹,Di Biase Stefano¹,Smith Drake J.¹,Zhou Yang¹,Li Yan-Ruide¹,Ma Feiyang²,Huang Jie¹,Clarke Nicole¹^ORCID,To Angela¹,Gong Laura¹^ORCID,Pham Alexander T.¹,Moon Heesung¹^ORCID,Pellegrini Matteo²³^ORCID,Yang Lili¹⁴⁵⁶^ORCID

Affiliation:

1. Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095, USA.

2. Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA 90095, USA.

3. Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095, USA.

4. Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA.

5. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA.

6. Jonsson Comprehensive Cancer Center, the David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

Abstract

Monoamine oxidase A (MAO-A) restrains antitumor T cell immunity, suggesting potential use of MAO-A inhibitors in cancer immunotherapy.

Funder

National Institutes of Health

Stop Cancer

Yale University

University of California, Los Angeles

University of South Alabama

Department of Health and Human Services, State Government of Victoria

Tower Cancer Research Foundation

Rose Hills Foundation

UCLA BSCRC

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine,Immunology

Reference51 articles.

1. Cancer Immunotherapy

2. Adoptive cell transfer as personalized immunotherapy for human cancer

3. The Principles of Engineering Immune Cells to Treat Cancer

4. Coinhibitory Pathways in Immunotherapy for Cancer

5. Immune Modulation in Cancer with Antibodies

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy;Science Advances;2024-09-13

2. Serotonin signalling in cancer: Emerging mechanisms and therapeutic opportunities;Clinical and Translational Medicine;2024-06-28

3. Doxorubicin induces deglycosylation of cancer cell‐intrinsic PD‐1 by NGLY1;FEBS Letters;2024-05-23

4. New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication;MedComm;2024-05-23

5. Immunotherapy for depression: Recent insights and future targets;Pharmacology & Therapeutics;2024-05